Skip to content

Irish Regulated Funds – The Ascent of Crypto

May 4, 2022

The European financial regulators continue to warn consumers that many crypto-assets are risky and are not suited for most retail consumers as an investment or as a means of payment or exchange. However, two recent fund approvals by the Irish regulator, The Central Bank of Ireland (the “CBI”) are being discussed as perhaps opening a new chapter for regulated investment funds that have exposure to crypto assets.

Authorized Investment funds that are authorized in Ireland are generally set up as either Undertakings for Collective Investment in Transferable Securities (UCITS) or non UCITS funds, Alternative Investment Funds (AIFs). There are two main types of AIF in Ireland, the Qualifying Investor AIF (“QIAIF”) and the Retail Investor AIF. The two fund approvals in question that were approved by the CBI were QIAIFs whose investment objective involved investing in cash-settled Bitcoin Futures traded on the Chicago Mercantile Exchange. In the case of a QIAIF seeking to gain exposure to crypto-assets, the relevant QIAIF would have needed to make a submission to the CBI outlining how the risks associated with such exposures could be managed effectively by an alternative investment fund manager

The approved QIAIFs will only be marketed to qualified investors, i.e., well-informed and professional investors and as the QIAIF is not subject to investment or borrowing restrictions, it can be used for a wide range of investment purposes.

The QIAIF has a proven track record as a regulated and flexible solution for alternative investment managers.

We at Clark Hill work with the market leaders in the administration, management, and depositary services in the establishment of QIAIFs and we look forward to working with new and existing clients who are desirous of investing in crypto-assets via a regulated structure.

Subscribe for the latest

Subscribe

Related

Event

Webinar- Dark Patterns in Healthcare: Navigating Patient Consent, Website Privacy, and Emerging Regulatory Risk 

Healthcare organizations increasingly rely on digital tools to engage patients, streamline intake, and improve care coordination. At the same time, regulators are closely scrutinizing whether online interfaces, consent mechanisms, and patient-facing technologies improperly influence or manipulate patient choices through so-called “dark patterns.”

Explore more
Legal Updates

Texas’ Hemp THC Crackdown is Now in Effect: What Businesses Need to Know

As of Jul. 31st, Texas is enforcing tough new restrictions on hemp-derived THC products, and it’s changing the game for manufacturers, distributors, and retailers across the state. This isn’t one new law; it’s the Texas Department of State Health Services’ (DSHS) messy revival of dormant 2021 rules after a Texas Supreme Court ruling, on top of separate consumable-hemp regulations that kicked in earlier this year and are still being fought over in court. Bottom line: the rules have shifted more than once in 2026, and businesses need a clear picture of what’s banned, what’s still fine, and what’s still up in the air.

Explore more
Legal Updates

Nasdaq's $5 Million MVLS Rule Approved: What Issuers Need to Know About the Final Rule and the SEC’s Temporary Stay of Effectiveness

The SEC has approved Nasdaq’s new $5 million Market Value of Listed Securities (MVLS) continued listing standard, while temporarily staying its effectiveness pending potential Commission review. Although the final rule retains Nasdaq’s accelerated delisting framework, it expands the Nasdaq Hearings Panel’s authority to grant limited relief, giving certain issuers additional time to demonstrate compliance with Nasdaq’s more stringent initial listing standards.

Explore more